Stocksigma LogoStocksigma Logo

Zenith Drugs Reports H1 FY27 Results with PAT Growth to ₹262.32 Lakh

Zenith Drugs reported total revenue from operations of ₹8,150.27 lakh for the half-year ended 30th Sep'26, up 4.19% YoY from ₹7,822.35 lakh

Zenith Drugs Reports H1 FY27 Results with PAT Growth to ₹262.32 Lakh

Zenith Drugs Ltd · Outcome · 14 Nov 2026, 9:12 pm

Zenith Drugs Reports H1 FY27 Results with PAT Growth to ₹262.32 Lakh Zenith Drugs reported total revenue from operations of ₹8,150.27 lakh for the half-year ended 30th Sep'26, up 4.19% YoY from ₹7,822.35 lakh. Total income reached ₹8,426.02 lakh compared to ₹8,013.81 lakh in H1 FY26. Net profit rose 12.32% YoY to ₹262.32 lakh from ₹233.55 lakh, with basic and diluted EPS improving to ₹1.53 per share from ₹1.36. Total expenses stood at ₹8,163.70 lakh versus ₹7,758.72 lakh, driven by ₹6,837.15 lakh in material costs. Total assets increased to ₹19,683.55 lakh.

Original exchange filing (PDF)

More announcements from Zenith Drugs Ltd

All Zenith Drugs Ltd announcements